scispace - formally typeset
Open AccessJournal ArticleDOI

Contribution of platelets to tumour metastasis.

Brunhilde Felding-Habermann
- 01 Feb 2011 - 
- Vol. 11, Iss: 2, pp 123-134
TLDR
Contributions of platelets to tumour cell survival and spread suggest platelets as a new avenue for therapy.
Abstract
Experimental evidence suggests that platelets contribute to metastasis through adhesive and haemostatic functions that promote cancer cell survival, immune evasion and interactions with vascular cells to assist organ colonization from the bloodstream. Extensive experimental evidence shows that platelets support tumour metastasis. The activation of platelets and the coagulation system have a crucial role in the progression of cancer. Within the circulatory system, platelets guard tumour cells from immune elimination and promote their arrest at the endothelium, supporting the establishment of secondary lesions. These contributions of platelets to tumour cell survival and spread suggest platelets as a new avenue for therapy.

read more

Citations
More filters
Journal ArticleDOI

Clinical models and biochemical predictors of VTE in lung cancer

TL;DR: The latest information concerning venous thrombophilic condition in cancer patients is summarized, with focus on some of the proposed strategies to select the appropriate patients for prophylaxis.
Journal ArticleDOI

Visualizing cancer extravasation: from mechanistic studies to drug development

TL;DR: This review focuses on recent progress in cancer extravasation visualization techniques, including the development of both in vitro and in vivo cancerExtravasation models, that shed light on the underlying mechanisms.
Journal ArticleDOI

Modulating barriers of tumor microenvironment through nanocarrier systems for improved cancer immunotherapy: a review of current status and future perspective.

TL;DR: This review aims to highlight the barriers offered by TME for hindering the efficiency of immunotherapy for cancer treatment, and highlights various nano-carriers based strategies for modulating those barriers for achieving better therapeutic efficacy of cancer immunotherapy with higher safety.
Journal ArticleDOI

Prognostic Impact of Increased Perioperative Platelet Count in Gastric Cancer Patients.

TL;DR: Platelet count could be a cost-effective biomarker for screening and monitoring patients with unfavorable survival outcomes and was an independent prognostic factor of overall survival in patients who underwent radical surgery.
Journal ArticleDOI

The Combination of Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio with Liquid Biopsy Biomarkers Improves Prognosis Prediction in Metastatic Pancreatic Cancer

TL;DR: In this article, a multi-parameter prognosis model was designed by combining neutrophil-lymphocyte ratio (NLR), platelet-lysiomachoroma ratio (PLR), circulating cell-free DNA (cfDNA) concentration, and circulating RAS mutation were determined.
References
More filters
Journal ArticleDOI

Tumor Angiogenesis: Therapeutic Implications

TL;DR: This new capillary growth is even more vigorous and continuous than a similar outgrowth of capillary sprouts observed in 2016 and is likely to be accompanied by neovascularization.
Journal ArticleDOI

Cancer Metastasis: Building a Framework

TL;DR: Understanding of the origins and nature of cancer metastasis and the selection of traits that are advantageous to cancer cells is promoted.
Journal ArticleDOI

Dissemination and growth of cancer cells in metastatic sites

TL;DR: Inhibition of the growth of metastases in secondary sites offers a promising approach for cancer therapy and could help to improve the treatment of metastatic disease.
Journal ArticleDOI

Microenvironmental regulation of metastasis

TL;DR: Experimental data demonstrating the role of the microenvironment in metastasis is described, areas for future research are identified and possible new therapeutic avenues are suggested.
Journal ArticleDOI

Integrins in cancer: biological implications and therapeutic opportunities

TL;DR: Clinical developments emphasize the need to identify how integrin antagonists influence the tumour and its microenvironment.
Related Papers (5)